AgenT

AgenT is a French biotechnology company founded in 2018, headquartered in Paris, focused on revolutionizing Alzheimer's disease diagnosis. The company is developing a multiomics blood test designed to detect Alzheimer's disease up to 20 years before the onset of irreversible symptoms. Its platform combines the analysis of proteins and metabolites in blood plasma with machine learning to decode the body's early response to the disease.